Clinical trials recruiting in Schorndorf, Germany

Phase breakdown

Conditions recruiting in Schorndorf, Germany

Recruiting trials in Schorndorf, Germany

• A Non-interventional Study for Kisqali (Ribociclib) in Combination With an Aromatase Inhibitor for Adjuvant Treatment in Patients With HR+/HER2- Early Breast Cancer at High Risk of Recurrence
  NCT06830720 · Phase: Not specified · Ages: 18 Years to 100 Years · Sex: All (male and female)
• BRAF Inhibitor Encorafenib And Cetuximab Real Life Investigation of Next Generation CRC Treatment
  NCT04673955 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)
• Binimetinib Plus Encorafenib Real Life Investigation of Next Generation Melanoma Treatment
  NCT04045691 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)
• UmbREALung - A Retrospective and Prospective, Observational, Real World Multi-cohort Study of Patients With Non-small Cell Lung Cancer (NSCLC) Initiating Approved Drugs Developed by AZ or as Part of an AZ Alliance
  NCT06726720 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Schorndorf, Germany?

4 recruiting trials have at least one study site in Schorndorf, Germany.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.